Shareholders Equity and Capital Stock (Details 7) |
6 Months Ended |
---|---|
Jun. 30, 2021
USD ($)
$ / shares
shares
| |
Aggregate Intrinsic Value | $ 7,602,650,000 |
Exercise price $1.00 | |
Exercise price | $ / shares | $ 1.00 |
Number of warrants | shares | 11,411,604 |
Remaining contractual life (years) | 2 months 12 days |
Aggregate Intrinsic Value | $ 2,282,321 |
Expiry | Sep. 25, 2021 |
Exercise price $0.75 | |
Exercise price | $ / shares | $ 0.75 |
Number of warrants | shares | 8,038,000 |
Remaining contractual life (years) | 1 year 1 month 6 days |
Aggregate Intrinsic Value | $ 2,612,350,000 |
Expiry | Aug. 04, 2022 |
Exercise price $1.35 | |
Exercise price | $ / shares | $ 1.35 |
Number of warrants | shares | 16,930,530 |
Remaining contractual life (years) | 2 years 7 months 6 days |
Aggregate Intrinsic Value | $ 423,263 |
Expiry | Feb. 04, 2024 |
Exercise price $1.10 | |
Exercise price | $ / shares | $ 1.11 |
Number of warrants | shares | 36,380,134 |
Remaining contractual life (years) | 1 year 6 months |
Aggregate Intrinsic Value | $ 5,317,934,000 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
X | ||||||||||
- Definition Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|